GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DuChemBio Co Ltd (XKRX:176750) » Definitions » Asset Turnover

DuChemBio Co (XKRX:176750) Asset Turnover : 0.69 (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is DuChemBio Co Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. DuChemBio Co's Revenue for the six months ended in Dec. 2023 was ₩34,695 Mil. DuChemBio Co's Total Assets for the quarter that ended in Dec. 2023 was ₩50,314 Mil. Therefore, DuChemBio Co's Asset Turnover for the quarter that ended in Dec. 2023 was 0.69.

Asset Turnover is linked to ROE % through Du Pont Formula. DuChemBio Co's annualized ROE % for the quarter that ended in Dec. 2023 was 40.63%. It is also linked to ROA % through Du Pont Formula. DuChemBio Co's annualized ROA % for the quarter that ended in Dec. 2023 was 15.90%.


DuChemBio Co Asset Turnover Historical Data

The historical data trend for DuChemBio Co's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DuChemBio Co Asset Turnover Chart

DuChemBio Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Turnover
Get a 7-Day Free Trial 0.66 0.70 0.26 0.58 0.69

DuChemBio Co Semi-Annual Data
Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Turnover Get a 7-Day Free Trial 0.66 0.70 0.26 0.58 0.69

Competitive Comparison of DuChemBio Co's Asset Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, DuChemBio Co's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DuChemBio Co's Asset Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, DuChemBio Co's Asset Turnover distribution charts can be found below:

* The bar in red indicates where DuChemBio Co's Asset Turnover falls into.



DuChemBio Co Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

DuChemBio Co's Asset Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=34695.49/( (51351.399+49276.827)/ 2 )
=34695.49/50314.113
=0.69

DuChemBio Co's Asset Turnover for the quarter that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2023 )/( (Total Assets (Q: Dec. 2022 )+Total Assets (Q: Dec. 2023 ))/ count )
=34695.49/( (51351.399+49276.827)/ 2 )
=34695.49/50314.113
=0.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


DuChemBio Co  (XKRX:176750) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

DuChemBio Co's annulized ROE % for the quarter that ended in Dec. 2023 is

ROE %**(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=8001.014/19694.1535
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(8001.014 / 69390.98)*(69390.98 / 50314.113)*(50314.113/ 19694.1535)
=Net Margin %*Asset Turnover*Equity Multiplier
=11.53 %*1.3792*2.5548
=ROA %*Equity Multiplier
=15.90 %*2.5548
=40.63 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) net income data. The Revenue data used here is two times the semi-annual (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

DuChemBio Co's annulized ROA % for the quarter that ended in Dec. 2023 is

ROA %(Q: Dec. 2023 )
=Net Income/Total Assets
=8001.014/50314.113
=(Net Income / Revenue)*(Revenue / Total Assets)
=(8001.014 / 69390.98)*(69390.98 / 50314.113)
=Net Margin %*Asset Turnover
=11.53 %*1.3792
=15.90 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2023) net income data. The Revenue data used here is two times the semi-annual (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


DuChemBio Co Asset Turnover Related Terms

Thank you for viewing the detailed overview of DuChemBio Co's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


DuChemBio Co (XKRX:176750) Business Description

Traded in Other Exchanges
N/A
Address
Daegu 47, Jinyang Building, 4th floor, Chungjeong-ro 2, Gyeonggi, Seoul, KOR, 190-3
DuChemBio Co Ltd is engaged in manufacturing and sale of radiopharmaceuticals and radioactive medicines. It also imports and sells medical equipment related to nuclear medicines.

DuChemBio Co (XKRX:176750) Headlines

No Headlines